FDA Inspection 1314374 — Qiagen GmbH
The FDA completed an inspection of Qiagen GmbH on Mar 12, 2026 in Hilden. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 12, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Project Evaluation: Devices
- Location
- Hilden (Germany)